XML 19 R6.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Operating activities:    
Net loss $ (1,089) $ (2,014)
Adjustments to reconcile net loss to net cash provided by operating activities, net of acquisition:    
Depreciation and amortization 2,154 1,673
Amortization finance lease 72 75
Change on operating lease (31) 81
Employee stock compensation expense 460 204
Provision for doubtful accounts 72  
Gain on disposal of property and equipment (1)  
Unrealized foreign currency gains 9 5
Financing lease interest expense 137 133
Interest payment true up (3)  
Changes in operating assets and liabilities:    
Accounts receivable (1,927) (1,873)
Inventories (172) (109)
Income tax accruals   102
Prepaid expenses and other assets 178 (723)
Accounts payable 770 (577)
Accrued expenses 66 (422)
Customer advances 3,831 3,791
Net cash provided by operating activities 4,526 346
Investing activities:    
Capital expenditures (2,427) (3,351)
Proceeds from sale of equipment 2  
Cash paid in acquisition   (4,000)
Net cash used in investing activities (2,425) (7,351)
Financing activities:    
Payments on finance lease liability (206) (212)
Payments of long-term debt (1,436) (603)
Payments of debt issuance costs (41) (111)
Payments on capex lines of credit (135)  
Payments on revolving line of credit   (22,711)
Borrowings on revolving line of credit   24,263
Borrowings on construction loans   1,089
Borrowings on capex lines of credit 387 1,329
Borrowings on long-term loan   3,533
Proceeds from exercise of stock options 111 20
Change in finance lease (1)  
Net cash used/provided by financing activities (1,321) 6,597
Net increase in cash and cash equivalents 780 (408)
Cash, cash equivalents, and restricted cash at beginning of period 1,406 606
Cash, cash equivalents, and restricted cash at end of period 2,186 198
Supplemental disclosure of cash flow information:    
Cash paid for interest $ 520 494
Preclinical Research Services acquisition:    
Assets acquired   6,442
Liabilities assumed   (1,378)
Common shares issued   (1,133)
Cash paid   $ 3,931